Agappe Diagnostics: Agappe Diagnostics and Fujirebio Holdings Partner to Create Diagnostic Tools

In Short: Agappe Diagnostics Ltd. has partnered with Fujirebio Holdings Inc. to launch India's first "Make in India" In-Vitro Biomarkers using CLEIA technology. This advancement enables early detection of diseases like Alzheimer's and cancer, improving treatment outcomes. The collaboration supports India's healthcare self-reliance and includes a new manufacturing facility in Kakkanad, enhancing Agappe's capabilities in [...]This news is sourced from India Telecom News.